21Shares XRP ETF

EDGAR

Market value

$111.03M

11,020,000 shares as of 2026-11-05, at $10.075 a share (TOXR, IEX close on 2026-11-12) Primary-source evidence

7 filing records in this dataset, filed from 2024-11-01 to 2026-11-10. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

No Form 3, 4 or 5 for this issuer is in the store. The store has read filings dated 1980-01-02 to 2026-11-20; this is not a statement that none were filed.

Institutional holders (Form 13F)

  • GOLDMAN SACHS GROUP INC 695,767 SH
  • Teucrium Investment Advisors, LLC 15,112 SH
  • FLOW TRADERS U.S. LLC 13,311 SH
  • SUSQUEHANNA INTERNATIONAL GROUP, LLP 12,572 SH
  • RPO LLC 10,400 SH

Trades by members of Congress

See all insider transactions

Short annual reporting periods

These figures cover less than a full year. They are not annualized and are excluded from full-year trends and comparisons.

Corrected figures
MeasurePeriodValue
Net income2024-12-20 – 2024-12-31-11323810 USD Source Dispute
Operating expenses2024-12-20 – 2024-12-31163196 USD Source Dispute
Cash and cash equivalents
Not available
Long-term debt including current maturities
Not available
Shares outstanding
Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-144 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence
  • Net income: -36024919 USD · 2025-01-01 – 2025-12-31 Source
  • Net income: 70543441 USD · 2025-01-01 – 2025-09-30 Source
  • Net income: -52307128 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -32933923 USD · 2026-04-01 – 2026-06-30 Source
  • Net income: 47798397 USD · 2026-07-01 – 2026-09-30 Source

Company performance

Up to ten complete financial years · consolidated figures

Latest filing vintage with reviewed corrections applied; these values remain separate from issuer-reported figures. Annual charts exclude incomplete years.

Latest filing recorded: 2026-11-10.

Financial data available through: 2025-12-31.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • operating income: No compatible figures in this window
  • Net income: 1 of 11 periods available· newest 2025-12-31
  • operating cash flow: No compatible figures in this window
  • capital expenditure: No compatible figures in this window
  • Total assets: 1 of 11 periods available· newest 2025-12-31
  • Total liabilities: 1 of 11 periods available· newest 2025-12-31
  • current assets: No compatible figures in this window
  • current liabilities: No compatible figures in this window
  • cash and cash equivalents: No compatible figures in this window
  • long term debt: No compatible figures in this window
  • shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

No unambiguous prior-year comparison is available for the latest reporting period.

Comparable inputs unavailable for: Revenue, Net income, Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2025 2025-01-01 – 2025-12-31
−USD 36.02 million
Exact value

Exact value: -36024919 USD

2025-01-01 – 2025-12-31: -36024919 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

7 filings · 94 latest values · 94 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0002028835, 2028835, TOXR, edgar:2028835

Also known as 21Shares Core XRP Trust, 21Shares XRP ETF